Cargando…

Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19

Gut microbiota (GM) modulation can be investigated as possible solution to enhance recovery after COVID-19. An open-label, single-center, single-arm, pilot, interventional study was performed by enrolling twenty patients recently recovered from COVID-19 to investigate the role of a mixed probiotic,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laterza, Lucrezia, Putignani, Lorenza, Settanni, Carlo Romano, Petito, Valentina, Varca, Simone, De Maio, Flavio, Macari, Gabriele, Guarrasi, Valerio, Gremese, Elisa, Tolusso, Barbara, Wlderk, Giulia, Pirro, Maria Antonia, Fanali, Caterina, Scaldaferri, Franco, Turchini, Laura, Amatucci, Valeria, Sanguinetti, Maurizio, Gasbarrini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094838/ https://www.ncbi.nlm.nih.gov/pubmed/37047594 http://dx.doi.org/10.3390/ijms24076623

Ejemplares similares

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
por: Caruso, C., et al.
Publicado: (2023)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
por: Scaldaferri, Franco, et al.
Publicado: (2023)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Clinical research coordinators: Key components of an efficient clinical trial unit
por: Mora, Vincenzina, et al.
Publicado: (2023)

Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota
por: Del Chierico, Federica, et al.
Publicado: (2021)

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis
por: Petito, Valentina, et al.
Publicado: (2019)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Potential of multiomics technology in precision medicine
por: Putignani, Lorenza, et al.
Publicado: (2019)

Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study
por: Graziani, Cristina, et al.
Publicado: (2022)

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease
por: Gaetani, Eleonora, et al.
Publicado: (2018)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

How the gut parasitome affects human health
por: Ianiro, Gianluca, et al.
Publicado: (2022)

The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease
por: Laterza, Lucrezia, et al.
Publicado: (2016)

Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
por: Ferraccioli, Gianfranco, et al.
Publicado: (2016)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives
por: Scaldaferri, F., et al.
Publicado: (2013)

Gut–Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis
por: de Sire, Alessandro, et al.
Publicado: (2020)

Gut Microbiota Ecology and Inferred Functions in Children With ASD Compared to Neurotypical Subjects
por: Vernocchi, Pamela, et al.
Publicado: (2022)

Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis
por: Caruso, Cristiano, et al.
Publicado: (2023)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
por: Ferraccioli, Gianfranco, et al.
Publicado: (2016)

Obesity as a Risk and Severity Factor in Rheumatic Diseases (Autoimmune Chronic Inflammatory Diseases)
por: Gremese, Elisa, et al.
Publicado: (2014)

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report
por: Caruso, C., et al.
Publicado: (2020)

Gut Microbiota Functional Traits, Blood pH, and Anti-GAD Antibodies Concur in the Clinical Characterization of T1D at Onset
por: Del Chierico, Federica, et al.
Publicado: (2022)

Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
por: De Maio, Flavio, et al.
Publicado: (2020)

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics
por: Vernocchi, Pamela, et al.
Publicado: (2017)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies
por: Di Vincenzo, Federica, et al.
Publicado: (2023)

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center
por: Pizzoferrato, Marco, et al.
Publicado: (2019)

JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy
por: Gremese, Elisa, et al.
Publicado: (2019)

Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions
por: Ristori, Maria Vittoria, et al.
Publicado: (2019)

Human gut microbiota: onset and shaping through life stages and perturbations
por: Putignani, Lorenza
Publicado: (2012)

HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
por: Gremese, Elisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a9bfn485mh0kst3nhuieheeed1